English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The association between autoimmune disease and risk of monoclonal malignancy is well studied. However, monoclonal B-cell lymphocytosis (MBL) in patients with autoimmune diseases has rarely been reported. The newly published 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms has officially accepted MBL as an independent disease entity.[1] Herein, we present a case of Wegener granulomatosis (WG) with MBL. Through this case, the diagnosis and management of MBL as a less known condition to rheumatologists, especially under the background of an autoimmune disorder, is reviewed. Moreover, the association between autoimmune disease and risk of monoclonal malignancy is discussed.

Monoclonal B-cell Lymphocytosis in a Patient with Wegener Granulomatosis